A synergistic antibacterial composite emulsion, its preparation method and application
By combining chitosan, carvone, jasmine ketone, and lactic acid bacteria bacteriocin in a quaternary compound and using a specific emulsification process, the problem of insufficient inhibition of Gram-positive and Gram-negative bacteria by existing antibacterial materials has been solved, achieving efficient and stable food preservation.
Patent Information
- Application Number
- CN202611352105.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-02
- Publication Date
- 2026-11-17
AI Technical Summary
Existing natural antibacterial materials are difficult to simultaneously and effectively inhibit Gram-positive and Gram-negative bacteria. The compound system is insufficient in terms of physical stability and retention rate of active ingredients. Furthermore, existing compound emulsions are prone to bacteriocin inactivation during the preparation process.
A quaternary compound of chitosan, carvone, jasmone, and lactobacillus bacteriocin is used to construct a cascade antibacterial system through a specific emulsification process and post-addition strategy, achieving synergistic antibacterial effects against Gram-positive and Gram-negative bacteria. A composite stabilization strategy of nonionic small molecule emulsifier and cationic high molecular weight polysaccharide is adopted to avoid damage to the active ingredients by high temperature shear.
It achieves a significant synergistic antibacterial effect against Gram-positive and Gram-negative bacteria, exhibits excellent physical stability of the emulsion, has a high retention rate of active ingredients, extends the shelf life of perishable fresh foods, and meets food safety requirements.
Smart Images

Figure CN123100697A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of food preservation, and more specifically, relates to a synergistic antibacterial composite emulsion containing chitosan, carvone, jasmone and lactic acid bacteria bacteriocin, its preparation method and application. Background Technology
[0002] With increasing public concern for food safety and public health, the development of efficient, safe, and broad-spectrum antimicrobial materials has become a research hotspot in fields such as food preservation and medical care. Naturally derived antimicrobial substances have attracted widespread attention due to their high safety and environmental friendliness.
[0003] Currently known natural antibacterial substances often struggle to simultaneously achieve highly effective inhibition against both Gram-positive and Gram-negative bacteria. For example, nisin exhibits significant inhibitory effects against Gram-positive bacteria such as Staphylococcus aureus, but its effect on Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa is extremely weak when used alone. While chitosan and some plant essential oils show some activity against both types of bacteria, the required concentrations are high when used alone, limiting their practical effectiveness. Therefore, achieving broad-spectrum, highly efficient, and synergistic inhibition of Gram-positive and Gram-negative bacteria in a single system is one of the important technical challenges currently facing the development of natural antibacterial materials.
[0004] Previous studies have attempted to combine chitosan with single plant essential oils or single bacteriocins to improve antibacterial effects. However, these binary or ternary compound systems often only achieve a simple additive effect, with limited enhancement of antibacterial activity, and do not fully consider the complementarity of the components in terms of their mechanisms of action. Furthermore, existing compound emulsions still have shortcomings in terms of physical stability, retention rate of active ingredients, and practical application effectiveness. For example, during emulsion preparation, high-pressure homogenization or ultrasonic treatment may inactivate protein-based active ingredients such as bacteriocins, thereby weakening the overall antibacterial performance of the system.
[0005] Therefore, a new compound system is needed to achieve synergistic antibacterial effects. Summary of the Invention
[0006] To address the above problems, the present invention provides a synergistic antibacterial composite emulsion comprising an antibacterial component, a moisturizer, an emulsifier, and a dispersion medium, wherein the antibacterial component comprises one or more of the following: 0.5%-3.0% chitosan, plant essential oil, and 0.005%-0.2% lactic acid bacteria bacteriocin; The plant essential oil contains 0.05%-1.5% carvone and 0.05%-1.5% jasmone.
[0007] In one specific implementation, the lactic acid bacteria bacteriocin is nisin.
[0008] In one specific embodiment, the humectant is 0.5%-5.0% glycerin; The emulsifier is 0.5%-5.0% Tween 80; The dispersion medium is water.
[0009] The present invention also provides a method for preparing the above-mentioned synergistic antibacterial composite emulsion, comprising the following steps: S1: Prepare an aqueous solution of chitosan-glycerol as the aqueous phase; S2: Mix carvone and jasmine in the prescribed amounts to obtain plant essential oil, and add emulsifier to obtain oil phase; S3: Under high-speed shearing or stirring conditions, the oil phase is slowly added to the aqueous phase to obtain a crude emulsion; S4: The crude emulsion is ultrasonically broken down under an ice bath to form a nano-emulsion; S5: Add lactic acid bacteria bacteriocin to the nanoemulsion and add the dispersion medium to adjust the volume to the formulation amount to obtain the synergistic antibacterial composite emulsion.
[0010] In one specific implementation, in S1, the mass concentration of chitosan in the aqueous phase is 0.5%–6.0%.
[0011] In one specific embodiment, in S2, the emulsifier is Tween 80, and the mass ratio of Tween 80 to the plant essential oil is 1:1 to 5:1.
[0012] In one specific implementation, the mass ratio of Tween 80 to the plant essential oil is 2:1 to 4:1.
[0013] In one specific implementation, in S5, the lactic acid bacteria bacteriocin is nisin, and when nisin is introduced, the system temperature is not higher than 25°C.
[0014] In one specific implementation, the method includes the following steps: S1: Add the prescribed amount of chitosan to an appropriate amount of ultrapure water, stir at 25–50°C for 2–4 hours to completely dissolve the chitosan, and obtain a chitosan solution of 0.5% to 6.0%. Add the prescribed amount of glycerol to the chitosan solution, stir evenly, and filter through a 0.45μm filter membrane to remove insoluble matter, and obtain the aqueous phase. S2: Mix carvone and jasmine in the prescribed amounts to obtain the plant essential oil, then add the prescribed amount of Tween 80, and stir or vortex mix at room temperature for 5–10 minutes to ensure that Tween 80 and the plant essential oil are fully miscible, thus obtaining the oil phase; S3: Under high-speed shearing or stirring conditions, the oil phase is slowly added to the aqueous phase, and shearing is continued for 3–10 minutes to form a milky white crude emulsion. The shearing speed is 8,000–12,000 rpm; the feeding rate is 1 / 10–1 / 5 of the total volume of the oil phase per minute. S4: The crude emulsion is treated with an ultrasonic cell disruptor under ice bath cooling to obtain a uniform nanoemulsion with a slightly bluish luster. The preferred ultrasonic treatment power is 300–400 W, the treatment time is 3–5 minutes, and the ultrasonic time / intermittent time ratio is 1:1 to 3:1.
[0015] S5: At 4–25°C, with gentle stirring (200–500 rpm), slowly add the formulated amount of nisin to the nanoemulsion, and continue stirring for 10–30 minutes to allow it to fully dissolve and adsorb onto the surface of the emulsion droplets; finally, bring the nanoemulsion to the formulated amount to obtain the synergistic antibacterial composite emulsion.
[0016] This invention also provides the application of synergistic antibacterial compound emulsion in food preservation.
[0017] This invention constructs a cascaded antibacterial system through the design of a multi-component synergistic mechanism. Employing a specific emulsification process and post-addition strategy, it achieves efficient retention of active ingredients and long-term emulsion stability. It exhibits significant synergistic antibacterial effects against both Gram-positive bacteria (Staphylococcus aureus) and Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa), overcoming the limitations of single-component systems with their narrow antibacterial spectrum and poor effectiveness against Gram-negative bacteria. This composite emulsion can effectively delay spoilage of perishable fresh foods such as aquatic products and chilled meat during refrigeration due to microbial proliferation, extending their shelf life and showing broad application prospects in the field of fresh food preservation.
[0018] Compared with the prior art, the synergistic antibacterial composite emulsion and its preparation method provided by the present invention have the following beneficial effects: 1. Significant multi-component synergistic antibacterial effect This invention constructs a cascade synergistic antibacterial mechanism of "cell wall disruption-membrane disturbance-perforation" by compounding chitosan, carvone, jasmone, and nisin in a specific ratio. Experiments have shown that this quaternary combination exhibits a synergistic inhibitory index (FICI) ≤0.5 against Staphylococcus aureus and Escherichia coli, indicating a strong synergistic effect. In combined use, the concentrations of each component are significantly lower than their minimum inhibitory concentrations (MICs) when used alone, achieving highly effective antibacterial activity at extremely low doses. This synergistic effect stems from the quaternary compounding technique (corresponding component and ratio design), rather than being achievable with a single component or a simple binary combination.
[0019] 2. It also exhibits excellent antibacterial activity against Gram-negative bacteria. Nisin alone is almost ineffective against Gram-negative bacteria (such as Escherichia coli), a well-known limitation in the art. In this invention, the positively charged chitosan and plant essential oil components can initially disrupt the outer membrane barrier of Gram-negative bacteria, allowing Nisin to penetrate and act on the cell membrane, thereby achieving effective inhibition of Gram-negative bacteria. This effect stems from the synergistic design of chitosan, essential oil, and Nisin.
[0020] 3. Excellent physical stability of the emulsion This invention employs a composite stabilization strategy of "nonionic small molecule emulsifier (Tween 80) + cationic high molecular weight polysaccharide (chitosan)". Tween 80 provides efficient emulsification and steric hindrance, while chitosan further stabilizes the emulsion by enhancing the mechanical strength of the interfacial film. The resulting emulsion has an average particle size at the nanoscale (e.g., 110.3 nm), a low TSI stability index, and a uniform appearance without stratification. This effect stems from the composite design of the emulsification system in the formulation (Tween 80 and chitosan synergistically stabilize the oil-water interface).
[0021] 4. Effectively preserves the bioactivity of nisin. This invention employs a "post-addition" process, introducing Nisin after the emulsion has been homogenized and cooled. This avoids the damage to the Nisin peptide chain structure caused by localized high temperatures and shear forces generated during high-pressure homogenization or ultrasonication. This process design maximizes the preservation of Nisin's antibacterial activity, which is a crucial guarantee for the significant antibacterial effect of the emulsion.
[0022] 5. Outstanding performance in actual food preservation applications When the emulsion of this invention is used for preserving crayfish meat, under refrigeration conditions of 4°C, it can extend the shelf life by at least 2 days compared to the control group, and the total bacterial count and TVB-N value are significantly better than those of the control group. This effect is attributed to the combined effect of the synergistic antibacterial properties, nanoparticle size, and stability described above.
[0023] 6. High security, in line with the trend of clean labeling. All components used in this invention are food-grade or pharmaceutical-grade raw materials. Chitosan, plant essential oils, and nisin are all natural or biologically derived substances. They do not contain traditional chemically synthesized preservatives and are suitable for fields with high safety requirements, such as food preservation, medical dressings, and cosmetics. Attached Figure Description
[0024] Figure 1 Photograph of the appearance of the composite emulsion.
[0025] Figure 2 Laser confocal microscopy image of the composite emulsion (Nile Red staining).
[0026] Figure 3The growth inhibition curves of the compound emulsion against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa are shown.
[0027] Figure 4 The curves show the changes in the total bacterial count of crayfish meat during refrigeration in the treatment and control groups.
[0028] Figure 5 The curves show the changes in volatile basic nitrogen (TVB-N) in crayfish meat during refrigeration in the treatment and control groups.
[0029] Figure 6 To compare the sensory scores of crayfish meat during refrigeration between the treatment group and the control group. Detailed Implementation
[0030] The principles and features of the present invention are described below with reference to the accompanying drawings. The examples given are only for explaining the present invention and are not intended to limit the scope of the present invention.
[0031] I. Raw material preparation and pretreatment The specifications of the main raw materials used in the embodiments are shown in Table 1.
[0032] Table 1 Specifications of Main Raw Materials
[0033] II. Process Flow for Emulsion Preparation Emulsions are prepared using the following method: 1) Preparation of the aqueous phase Add the prescribed amount of chitosan to an appropriate amount of ultrapure water and stir at 25–50°C for 2–4 hours until the chitosan is completely dissolved, obtaining a clear and transparent chitosan solution. Add the prescribed amount of glycerol to the chitosan solution and stir until homogeneous. Filter the solution through a 0.45 μm filter membrane to remove insoluble matter, obtaining the aqueous phase. (Key process parameter: the mass concentration of chitosan in the aqueous phase is 0.5%–6.0%.) 2) Preparation of the oil phase Mix carvone and jasmine ketone in the prescribed amounts, then add Tween 80 in the prescribed amounts. Stir or vortex at room temperature (20–30°C) for 5–10 minutes to ensure that Tween 80 and the essential oils are fully miscible, resulting in a clear oil phase mixture. (Key process parameters: The mass ratio of Tween 80 to the mixed essential oils is 1:1 to 5:1; preferably 2:1 to 4:1.) 3) Preparation of nanoemulsions (pre-emulsification) Under high-speed shearing or stirring conditions, the oil phase obtained in step 2 is slowly added to the aqueous phase obtained in step 1, and shearing is continued for 3–10 minutes to form a milky white crude emulsion. (Key process parameters: shearing speed is 5,000–15,000 rpm; preferably 8,000–12,000 rpm; feeding rate is 1 / 10–1 / 5 of the total oil phase volume per minute.) 4) Preparation of nanoemulsions (homogenization and refinement) The crude emulsion obtained in step 3 was treated with an ultrasonic cell disruptor under ice bath cooling (ultrasonic power 200–600 W, ultrasonic time, work / intermittent time ratio 1:1 to 3:1) to obtain a uniform nanoemulsion with a slightly bluish opalescent luster. (Key process parameters: ultrasonic treatment power preferably 300–400 W, treatment time 3–5 minutes.) 5) Introduction of the antibacterial factor Nisin The nanoemulsion obtained in step 4 is cooled to 4–25°C. Under gentle stirring (200–500 rpm), the prescribed amount of nisin is slowly added to the emulsion in powder form or pre-dissolved in a small amount of sterile water / dilute hydrochloric acid (pH 3.0–4.0). Stirring continues for 10–30 minutes to ensure complete dissolution and adsorption onto the surface of the emulsion droplets. Finally, the emulsion is brought to the prescribed volume to obtain the synergistic antibacterial composite emulsion. (Key process parameter: The emulsion temperature must be ≤ 25°C when Nisin is added to avoid inactivation of Nisin due to high temperature.) The components of the final synergistic antibacterial composite emulsion are shown in Table 2.
[0034] Table 2 shows the components in the composite emulsion by mass percentage:
[0035] III. Methods for Testing and Evaluating Emulsion Performance 1) Particle size, polydispersity index (PDI), and zeta potential determination The average hydrated particle size and polydispersity index of the emulsion were determined by dynamic light scattering (DLS), and the zeta potential of the emulsion droplet surface was determined by laser Doppler electrophoresis. Before testing, the emulsion samples were diluted 100-fold with ultrapure water to avoid multiple scattering effects. The measurement temperature was 25℃, the equilibration time was 120 seconds, and each sample was measured three times, with the average value taken. The instrument used was a Malvern nanoparticle size potentiometer.
[0036] 2) Physical stability determination (Turbiscan method) A Turbiscan multiple light scattering stability analyzer was used to scan and analyze the undiluted stock emulsion at 25°C. The scanning duration was 3500 seconds with a scanning interval of 100 seconds. The changes of transmitted light and backscattered light signals over time were recorded, and the Turbiscan Stability Index (TSI) was calculated. A lower TSI value indicates higher emulsion stability.
[0037] 3) Micro-morphology observation (Confocal Laser Scanning Microscopy, CLSM) An appropriate amount of emulsion sample was taken, Nile red fluorescent dye was added (final concentration 0.1 mg / mL), and the sample was stained in the dark for 30 minutes. 20 μL of the stained sample was dropped onto a glass slide, covered with a coverslip, and observed under a confocal laser scanning microscope. The excitation wavelength of Nile red was 488 nm, and the emission wavelength was 500–600 nm. Nile red is a lipophilic fluorescent probe that can selectively stain essential oil droplets to make them show red fluorescence, while the aqueous phase does not develop color.
[0038] 4) Determination of Fractional Inhibitory Concentration Index (FICI) The checkerboard micro-broth dilution method was adopted.
[0039] Determination of single-agent MIC: Stock solutions of chitosan solution, carvone emulsion, jasmone emulsion, and nisin (Nisin) solution were prepared respectively. 2-fold serial dilution was performed in a 96-well plate using LB medium, and Escherichia coli ATCC 25922 or Staphylococcus aureus ATCC 25923 in the logarithmic growth phase was inoculated to a final concentration of approximately 5×10 5 CFU / mL. After incubation at 35–37°C for 24 hours, the minimum concentration that completely inhibited visible growth was defined as the single-agent MIC.
[0040] Determination of combined FICI: Based on the respective MIC values of the four active substances, a combined mother liquor in which the concentration of each component was equal to its single-agent MIC was prepared according to the mass ratio of each active component in the emulsion of the present invention. 2-fold serial dilution was carried out in a 96-well plate, and the inoculation and incubation conditions were the same as those for single-agent MIC determination. The minimum combined concentration that completely inhibited growth under the combined action was recorded, and FICI was calculated according to the following formula: FICI = Cchitosan / MICchitosan + Ccarvone / MICcarvone + Cjasmone / MICjasmone + CNisin / MICNisin Wherein, C is the actual concentration of the component in the combined inhibition well. Criteria: FICI ≤ 0.5 indicates strong synergy, 0.5 < FICI ≤ 0.75 indicates synergy, 0.75 < FICI ≤ 1 indicates additivity, and FICI > 1 indicates antagonism.
[0041] 5) Determination of antibacterial effect by growth curve method Take the emulsion from the example, dilute it to a suitable concentration with LB medium, and inoculate it with the test strain to a final concentration of approximately 5 × 10⁻⁶. 5 CFU / mL. A growth control without emulsion was used. The cells were incubated at 35–37°C with shaking for 48 hours, and the OD600 value was measured every 4 hours to plot the growth curve.
[0042] 6) Evaluation of the application effect of aquatic product preservation Fresh, peeled crayfish meat was soaked in the emulsion from the example for a certain period of time, with sterile water treatment serving as a control. After draining, it was stored at 4°C. Samples were taken every 48 hours, and the total bacterial count was determined according to GB 4789.2, and the volatile basic nitrogen (TVB-N) was determined according to GB 5009.228. Sensory evaluation was also performed. Each group had three replicates. Example Example
[0043] According to the preparation method described in this invention, 2.0 g of chitosan, 0.5 g of carvone, 0.5 g of jasmone, 3.0 g of Tween 80, 5.0 g of glycerol, and 0.04 g of nisin were weighed and operated according to steps 1 to 5, wherein step 1 was the chitosan dissolution temperature of 40℃; step 3 was the shearing speed of 10000 rpm and the time of 5 minutes; step 4 was the ultrasonic power of 350W, the processing time of 4 minutes, and the working / intermittent time ratio of 2:1; and step 5 was the emulsion temperature of 25℃ and the stirring time of 20 minutes when Nisin was added, and water was added to make up to 100 g.
[0044] The resulting emulsion had an average particle size of 110.3 nm, a PDI of 0.308, a Zeta potential of +1.45 mV, a TSI (3500s) of 3.21, a FICI of 0.315 against Escherichia coli, and a FICI of 0.438 against Staphylococcus aureus.
[0045] The emulsion appears as a uniform milky white liquid with a slight bluish sheen. After standing, it shows no layering or sedimentation (see...). Figure 1 Laser confocal microscopy revealed that the essential oil droplets stained with Nile Red exhibited red fluorescence; the droplets were regular spherical, uniformly dispersed, and without aggregation (see...). Figure 2 ).
[0046] Example 2 (Chitosan dosage changed to 1%): The other preparation steps are the same as in Example 1, except that the amount of chitosan used is changed to 1.0 g (final concentration 1 wt%).
[0047] The resulting emulsion had an average particle size of 135.6 nm, a PDI of 0.289, and a FICI of 0.625 against Staphylococcus aureus. These results indicate that the emulsion remained nanoscale even after reducing the amount of chitosan used, while maintaining a synergistic antibacterial effect.
[0048] Example 3 (Chitosan dosage changed to 3%): The other preparation steps are the same as in Example 1, except that the amount of chitosan used is changed to 3.0 g (final concentration 3wt%).
[0049] The resulting emulsion had an average particle size of 125.4 nm, a PDI of 0.320, and a FICI of 0.56 against Staphylococcus aureus. These results indicate that increasing the amount of chitosan can also form a stable synergistic antibacterial nanoemulsion.
[0050] Example 4 (Essential oil ratio adjustment): The other preparation steps are the same as in Example 1, except that the amount of carvone is changed to 0.2 g and the amount of jasmine is changed to 0.8 g.
[0051] The resulting emulsion had an average particle size of 118.5 nm, a PDI of 0.295, and a FICI of 0.438 against Staphylococcus aureus.
[0052] V. Antibacterial effect of emulsion Using the growth curve method described in this invention, the composite emulsion obtained in Example 1 was diluted with LB medium to a final concentration of 1% (v / v), and then inoculated with *Escherichia coli* ATCC 25922, *Staphylococcus aureus* ATCC 25923, and *Pseudomonas aeruginosa* ATCC 27853 to a final concentration of approximately 5 × 10⁻⁶. 5 CFU / mL, with LB medium without emulsion as the growth control. Cultured at 35℃ with shaking for 48 hours, with OD600 values measured every 4 hours.
[0053] The results are as follows Figure 3 As shown, compared with the control group, the emulsion in Example 1 showed a significant growth inhibitory effect on all three test bacteria, with an OD of 12 hours. 600 It remains at the initial level, while the control group has entered the logarithmic growth phase.
[0054] VI. Application of compound emulsions in the preservation of crayfish meat Fresh, peeled crayfish meat was randomly divided into two groups, with three replicates in each group. The treatment group was completely immersed in the composite emulsion obtained in Example 1 for 5 minutes; the control group was soaked in sterile water for the same time. After draining, the meat was placed in sterile homogenization bags and stored at 4°C. Following the method for evaluating the effectiveness of aquatic product preservation described in this invention, samples were taken every 48 hours to determine the total bacterial count and volatile basic nitrogen (TVB-N), and sensory evaluation was performed.
[0055] The results are as follows Figure 4 , Figure 5 and Figure 6As shown in the figure, the control group had a total bacterial count exceeding 6 log CFU / g on day 4 of refrigeration and a TVB-N value exceeding 20 mg / 100 g on day 2 of refrigeration, with a low sensory score and obvious spoilage. The treatment group, however, maintained a total bacterial count below 6 log CFU / g on day 6 of refrigeration and a TVB-N value below 20 mg / 100 g on day 4 of refrigeration, with a significantly better sensory score than the control group. These results indicate that the composite emulsion of this invention can effectively extend the refrigerated shelf life of crayfish meat by at least 2 days.
[0056] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the protection scope of the present invention.
Claims
1. A synergistic antibacterial composite emulsion, characterized in that, It comprises an antibacterial component, a humectant, an emulsifier, and a dispersion medium, wherein the antibacterial component comprises one or more of the following: 0.5%-3.0% chitosan, plant essential oil, and 0.005%-0.2% lactic acid bacteria bacteriocins; The plant essential oil contains 0.05%-1.5% carvone and 0.05%-1.5% jasmone.
2. The synergistic antibacterial composite emulsion according to claim 1, characterized in that, The lactic acid bacteria bacteriocin mentioned is nisin.
3. The synergistic antibacterial composite emulsion according to claim 1, characterized in that, The moisturizer is 0.5%-5.0% glycerin; The emulsifier is 0.5%-5.0% Tween 80; The dispersion medium is water.
4. A method for preparing the synergistic antibacterial composite emulsion according to any one of claims 1-3, characterized in that, Includes the following steps: S1: Prepare an aqueous solution of chitosan-glycerol as the aqueous phase; S2: Mix carvone and jasmine in the prescribed amounts to obtain plant essential oil, and add emulsifier to obtain oil phase; S3: Under high-speed shearing or stirring conditions, the oil phase is slowly added to the aqueous phase to obtain a crude emulsion; S4: The crude emulsion is ultrasonically broken down under an ice bath to form a nano-emulsion; S5: Add lactic acid bacteria bacteriocin to the nanoemulsion and add the dispersion medium to adjust the volume to the formulation amount to obtain the synergistic antibacterial composite emulsion.
5. The method according to claim 4, characterized in that, In S1, the mass concentration of chitosan in the aqueous phase is 0.5%–6.0%.
6. The method according to claim 4, characterized in that, In S2, the emulsifier is Tween 80, and the mass ratio of Tween 80 to the plant essential oil is 1:1 to 5:
1.
7. The method according to claim 6, characterized in that, The mass ratio of Tween 80 to the plant essential oil is 2:1 to 4:
1.
8. The method according to claim 4, characterized in that, In S5, the lactic acid bacteria bacteriocin is nisin, and when nisin is introduced, the system temperature is not higher than 25°C.
9. The method according to any one of claims 4-8, characterized in that, Includes the following steps: S1: Add the prescribed amount of chitosan to an appropriate amount of ultrapure water, stir at 25–50°C for 2–4 hours to completely dissolve the chitosan, and obtain a chitosan solution of 0.5% to 6.0%. Add the prescribed amount of glycerol to the chitosan solution, stir evenly, and filter through a 0.45μm filter membrane to remove insoluble matter, and obtain the aqueous phase. S2: Mix carvone and jasmine in the prescribed amounts to obtain the plant essential oil, then add the prescribed amount of Tween 80, and stir or vortex mix at room temperature for 5–10 minutes to ensure that Tween 80 and the plant essential oil are fully miscible, thus obtaining the oil phase; S3: Under high-speed shearing or stirring conditions, the oil phase is slowly added to the aqueous phase, and shearing is continued for 3–10 minutes to form a milky white crude emulsion. The shearing speed is 8,000–12,000 rpm; the feeding rate is 1 / 10–1 / 5 of the total volume of the oil phase per minute. S4: The crude emulsion is treated with an ultrasonic cell disruptor under ice bath cooling to obtain a uniform nanoemulsion with a slightly bluish luster. The preferred ultrasonic treatment power is 300–400 W, the treatment time is 3–5 minutes, and the ultrasonic time / intermittent time ratio is 1:1 to 3:
1. S5: At 4–25°C, with gentle stirring (200–500 rpm), slowly add the formulated amount of nisin to the nanoemulsion, and continue stirring for 10–30 minutes to allow it to fully dissolve and adsorb onto the surface of the emulsion droplets; finally, bring the nanoemulsion to the formulated amount to obtain the synergistic antibacterial composite emulsion.
10. The application of the synergistic antibacterial composite emulsion according to any one of claims 1-3 in food preservation.
